Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Bloch

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|July 30, 2013
What does ALLHAT tell us about dyslipidemia from the hypertension specialist perspective?Michael J Bloch
Journal of the American College of Cardiology|July 18, 2020
Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?Michael J Bloch
Journal of the American Society of Hypertension : JASH|June 10, 2016
Spironolactone is the Most Effective "add-on" Medication For Resistant HypertensionMichael J Bloch
Journal of the American Society of Hypertension : JASH|September 24, 2016
Worldwide prevalence of hypertension exceeds 1.3 billionMichael J Bloch
Journal of the American Society of Hypertension : JASH|June 25, 2017
The Dietary Approaches to Stop Hypertension (DASH) diet-Promise UnmetMichael J Bloch
Journal of Clinical Hypertension (Greenwich, Conn.)|February 3, 2007
British hypertension society recommends that beta-blockers are no longer indicated as initial treatment of hypertension: has the pendulum swung too far?Michael J Bloch
Journal of the American Society of Hypertension : JASH|April 13, 2016
GIVING PHARMACISTS ABILITY TO PRESCRIBE ANTIHYPERTENSION MEDICATIONS CAN IMPROVE BLOOD PRESSURE CONTROL RATESMichael J Bloch
Journal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2007
Do angiotensin receptor antagonists decrease hsCRP independent of blood pressure - and does it matter?Michael J Bloch
Journal of the American Society of Hypertension : JASH|July 14, 2016
Blood pressure effects of SGLT2 inhibitors make them an attractive option in diabetic patients with hypertensionMichael J Bloch
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
Lower levels of microalbuminuria are associated with an increased risk of coronary heart disease and death in hypertensive subjectsMichael J Bloch, Jan Basile
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Journal of Clinical Hypertension (Greenwich, Conn.)|July 30, 2013
What does ALLHAT tell us about dyslipidemia from the hypertension specialist perspective?Michael J Bloch
Journal of the American College of Cardiology|July 18, 2020
Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?Michael J Bloch
Journal of the American Society of Hypertension : JASH|June 10, 2016
Spironolactone is the Most Effective "add-on" Medication For Resistant HypertensionMichael J Bloch
Journal of the American Society of Hypertension : JASH|September 24, 2016
Worldwide prevalence of hypertension exceeds 1.3 billionMichael J Bloch
Journal of the American Society of Hypertension : JASH|June 25, 2017
The Dietary Approaches to Stop Hypertension (DASH) diet-Promise UnmetMichael J Bloch
Journal of Clinical Hypertension (Greenwich, Conn.)|February 3, 2007
British hypertension society recommends that beta-blockers are no longer indicated as initial treatment of hypertension: has the pendulum swung too far?Michael J Bloch
Journal of the American Society of Hypertension : JASH|April 13, 2016
GIVING PHARMACISTS ABILITY TO PRESCRIBE ANTIHYPERTENSION MEDICATIONS CAN IMPROVE BLOOD PRESSURE CONTROL RATESMichael J Bloch
Journal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2007
Do angiotensin receptor antagonists decrease hsCRP independent of blood pressure - and does it matter?Michael J Bloch
Journal of the American Society of Hypertension : JASH|July 14, 2016
Blood pressure effects of SGLT2 inhibitors make them an attractive option in diabetic patients with hypertensionMichael J Bloch
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
Lower levels of microalbuminuria are associated with an increased risk of coronary heart disease and death in hypertensive subjectsMichael J Bloch, Jan Basile
Pageof 12